Binding Site Information of Target
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T11764 | Target Info | |||
Target Name | Discoidin domain-containing receptor 2 (DDR2) | ||||
Synonyms | Tyrosine-protein kinase TYRO10; Receptor protein-tyrosine kinase TKT; Neurotrophic tyrosine kinase, receptor-related 3; Discoidin domain-containing receptor tyrosine kinase 2; Discoidin domain receptor 2; DDR2; CD167 antigen-like family member B | ||||
Target Type | Patented-recorded Target | ||||
Gene Name | DDR2 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: 2-[4,5-bis(fluoranyl)-2-oxidanylidene-1'-(1~{H}-pyrazolo[3,4-b]pyridin-5-ylcarbonyl)spiro[indole-3,4'-piperidine]-1-yl]-~{N}-[2,2,2-tris(fluoranyl)ethyl]ethanamide | Ligand Info | |||||
Structure Description | Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide | PDB:6FER | ||||
Method | X-ray diffraction | Resolution | 2.87 Å | Mutation | No | [1] |
PDB Sequence |
VAVEEFPRKL
609 LTFKEKLGEG619 QFGEVHLCEV629 EGPVLVAVKM656 LRADANKNAR666 NDFLKEIKIM 676 SRLKDPNIIH686 LLAVCITDDP696 LCMITEYMEN706 GDLNQFLSRH716 TVSYTNLKFM 737 ATQIASGMKY747 LSSLNFVHRD757 LATRNCLVGK767 NYTIKIADFG777 MSRNLYSGDY 787 YRIQGRAVLP797 IRWMSWESIL807 LGKFTTASDV817 WAFGVTLWET827 FTFCQEQPYS 837 QLSDEQVIEN847 TGEFFRDQGR857 QTYLPQPAIC867 PDSVYKLMLS877 CWRRDTKNRP 887 SFQEIHLLLL897 Q
|
|||||
|
LEU616
3.753
VAL624
3.075
ALA653
3.515
LYS655
3.797
GLU672
3.643
MET676
3.373
LEU679
3.796
ILE684
3.668
ILE685
3.296
LEU687
4.473
MET699
3.327
ILE700
3.798
THR701
3.017
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome. ACS Chem Biol. 2019 Jan 18;14(1):37-49. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.